About Michael Beckloff
Michael Beckloff is a director at Bond Biosciences.
Michael Beckloff first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Beckloff in the role, so the role may have started earlier or lasted longer.
Bond Biosciences, Inc.
Director
2022 – 2026 · Parkville, MO
Develops oral drugs for people with diseases caused by excess ions.
Key Colleagues at Startups
The people Michael Beckloff works with at each company, as listed on that company's latest Form D.
Bond Biosciences, Inc. · Form D/A, Oct 5, 2026
Cory Berkland
Chairman
TO
Timothy Opler
Director
Michael Riley
Executive officer and director
JS
Jay Shepard
Director